Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-001097
Filing Date
2025-02-18
Accepted
2025-02-18 16:30:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10764
2 JOINT FILING AGREEMENT p25-0529exhibit99_1.htm EX-99.1 5646
  Complete submission text file 0000902664-25-001097.txt   18210
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89366 | Film No.: 25635460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131
Business Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131 201-391-1839
C/M CAPITAL PARTNERS, LP (Filed by) CIK: 0002038499 (see all company filings)

EIN.: 991188042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G